{"agent_type":"manual_validation_of_automated_agent","category":["biolink:EntityToDiseaseAssociation"],"clinical_approval_status":"off_label_use","id":"897ef74c-7451-33a0-b314-accff185d73c","knowledge_level":"observation","number_of_cases":11,"object":"MONDO:0020590","object_category":["biolink:Disease"],"object_name":"mycobacterial infectious disease","original_object":"Mycobacterial infection","original_subject":"TYGACIL","predicate":"biolink:applied_to_treat","sources":[{"resource_id":"infores:drugapprovals-kp","resource_role":"primary_knowledge_source","source_record_urls":["https://db.systemsbiology.net/gestalt/cgi-pub/KGinfo.pl?id=897ef74c-7451-33a0-b314-accff185d73c"],"upstream_resource_ids":["infores:dailymed","infores:faers","infores:canada-vigilance"]},{"resource_id":"infores:faers","resource_role":"supporting_data_source","source_record_urls":["https://www.fda.gov/safety/fda-adverse-event-monitoring-system-aems"]},{"resource_id":"infores:dailymed","resource_role":"supporting_data_source"},{"resource_id":"infores:canada-vigilance","resource_role":"supporting_data_source"}],"subject":"UMLS:C1614700","subject_category":["biolink:ChemicalEntity"],"subject_name":"Tygacil","supporting_text":["object_nlp_level: 1","subject_nlp_level: 1"]}